Mark A. Fletcher

1.8k total citations
61 papers, 1.3k citations indexed

About

Mark A. Fletcher is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Mark A. Fletcher has authored 61 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Epidemiology, 15 papers in Microbiology and 14 papers in Infectious Diseases. Recurrent topics in Mark A. Fletcher's work include Pneumonia and Respiratory Infections (27 papers), Respiratory viral infections research (22 papers) and Pneumocystis jirovecii pneumonia detection and treatment (13 papers). Mark A. Fletcher is often cited by papers focused on Pneumonia and Respiratory Infections (27 papers), Respiratory viral infections research (22 papers) and Pneumocystis jirovecii pneumonia detection and treatment (13 papers). Mark A. Fletcher collaborates with scholars based in United States, France and United Kingdom. Mark A. Fletcher's co-authors include Nancy G. Klimas, Robert O. Morgan, F Salvato, Bernard Fritzell, M. Ashman, Margaret A. Fischl, Luc Hessel, Bradford D. Gessner, Rafaele Dumas and James H. Stark and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Mark A. Fletcher

56 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Fletcher United States 18 418 356 266 183 156 61 1.3k
J M Galama Netherlands 28 627 1.5× 876 2.5× 529 2.0× 181 1.0× 256 1.6× 56 2.6k
Michael W. McKendrick United Kingdom 16 642 1.5× 120 0.3× 196 0.7× 46 0.3× 47 0.3× 49 1.4k
Macpherson Mallewa Malawi 21 320 0.8× 176 0.5× 589 2.2× 106 0.6× 53 0.3× 46 1.4k
Brent L. Williams United States 18 664 1.6× 438 1.2× 530 2.0× 471 2.6× 122 0.8× 21 2.5k
Toni Whistler United States 21 387 0.9× 349 1.0× 212 0.8× 27 0.1× 98 0.6× 62 1.4k
Keith Redhead United Kingdom 23 551 1.3× 143 0.4× 400 1.5× 777 4.2× 243 1.6× 54 1.8k
Ben Z. Katz United States 29 744 1.8× 588 1.7× 871 3.3× 74 0.4× 431 2.8× 119 3.0k
Shelley Rhodes United Kingdom 24 868 2.1× 79 0.2× 1.1k 4.0× 180 1.0× 432 2.8× 56 2.0k
Jochem M. D. Galama Netherlands 28 709 1.7× 42 0.1× 716 2.7× 193 1.1× 367 2.4× 53 2.1k
Michael Pietsch Germany 22 136 0.3× 226 0.6× 141 0.5× 153 0.8× 29 0.2× 52 1.6k

Countries citing papers authored by Mark A. Fletcher

Since Specialization
Citations

This map shows the geographic impact of Mark A. Fletcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Fletcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Fletcher more than expected).

Fields of papers citing papers by Mark A. Fletcher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Fletcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Fletcher. The network helps show where Mark A. Fletcher may publish in the future.

Co-authorship network of co-authors of Mark A. Fletcher

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Fletcher. A scholar is included among the top collaborators of Mark A. Fletcher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Fletcher. Mark A. Fletcher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Arciniegas, J, Frank J. Gonzalez, James A. Oñate, et al.. (2024). RWD174 Health Care Resources Associated with Clinical Pneumonia, Bacteremia or Meningitis in Colombian Adults: A Retrospective Database Study. Value in Health. 27(6). S391–S391.
5.
6.
Mahboub, Bassam, et al.. (2024). Retrospective Analysis of RSV Infection in Pediatric Patients: Epidemiology, Comorbidities, Treatment, and Costs in Dubai (2014-2023). Journal of health economics and outcomes research. 133–144. 2 indexed citations
7.
Méroc, Estelle, Mark A. Fletcher, Germaine Hanquet, et al.. (2023). Systematic Literature Review of the Epidemiological Characteristics of Pneumococcal Disease Caused by the Additional Serotypes Covered by the 20-Valent Pneumococcal Conjugate Vaccine. Microorganisms. 11(7). 1816–1816. 9 indexed citations
8.
Phongsamart, Wanatpreeya, Kristen E. Allen, Chonnamet Techasaensiri, et al.. (2023). Outcomes among Thai children with risk conditions hospitalized for pneumococcal disease (invasive or non-bacteraemic pneumonia): A multi-centre, observational study. IJID Regions. 8. 49–57. 3 indexed citations
9.
Vyse, Andrew, Andreas Pilz, Thao Mai Phuong Tran, et al.. (2023). Incidence of Lyme Borreliosis in Europe: A Systematic Review (2005–2020). Vector-Borne and Zoonotic Diseases. 23(4). 172–194. 35 indexed citations
10.
Tran, Thao Mai Phuong, Andreas Pilz, Andrew Vyse, et al.. (2023). Incidence of Lyme Borreliosis in Europe from National Surveillance Systems (2005–2020). Vector-Borne and Zoonotic Diseases. 23(4). 156–171. 42 indexed citations
11.
Pilz, Andreas, Andrew Vyse, Frederick J. Angulo, et al.. (2023). Seroprevalence of Lyme Borreliosis in Europe: Results from a Systematic Literature Review (2005–2020). Vector-Borne and Zoonotic Diseases. 23(4). 195–220. 21 indexed citations
12.
Fletcher, Mark A., Paul Koki Ndombo, Sinata Koulla‐Shiro, et al.. (2021). Impact of 13-valent pneumococcal conjugate vaccine on laboratory-confirmed pneumococcal meningitis and purulent meningitis among children ˂5 years in Cameroon, 2011–2018. PLoS ONE. 16(4). e0250010–e0250010. 3 indexed citations
13.
Fletcher, Mark A., Jose A Suaya, Sally Jackson, et al.. (2020). Diabetes mellitus as a vaccine-effect modifier: a review. Expert Review of Vaccines. 19(5). 445–453. 20 indexed citations
14.
Fletcher, Mark A., et al.. (2020). Development of a Logic Model to Guide Implementation and Evaluation of a Mobile Integrated Health Transitional Care Program. Population Health Management. 24(2). 275–281. 12 indexed citations
15.
Wasserman, Matt, et al.. (2018). Modeling Possible Inclusion of Pneumococcal Conjugate Vaccine into the National Immunization Program for Infants in India. Value in Health Regional Issues. 15. 99–105. 4 indexed citations
16.
Fletcher, Mark A., Paul Balmer, É. Bonnet, & Nathalie Dartois. (2015). PCVs in individuals at increased risk of pneumococcal disease: a literature review. Expert Review of Vaccines. 14(7). 975–1030. 16 indexed citations
17.
Fletcher, Mark A.. (2009). Discordant immunization schedules can complicate vaccine evaluation for Europe. Italian Journal of Public Health. 6(3). 2 indexed citations
18.
Fletcher, Mark A., et al.. (2002). Time to recommend pneumococcal vaccination for all children in Europe: experience in France. European Journal of Pediatrics. 161(0). S132–S134. 6 indexed citations
19.
Fletcher, Mark A., Marek Kloczewiak, Paul M. Loiselle, et al.. (1997). A Novel Peptide-IgG Conjugate, CAP18106-138-IgG, that Binds and Neutralizes Endotoxin and Kills Gram-Negative Bacteria. The Journal of Infectious Diseases. 175(3). 621–632. 18 indexed citations
20.
Míguez‐Burbano, Maria José, Gail Shor‐Posner, Mark A. Fletcher, et al.. (1995). Immunoglobulin E levels in relationship to HIV‐1 disease, route of infection, and vitamin E status. Allergy. 50(2). 157–161. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J M Galama Breakdown of academic impact, for papers by Michael W. McKendrick Breakdown of academic impact, for papers by Macpherson Mallewa Breakdown of academic impact, for papers by Brent L. Williams Breakdown of academic impact, for papers by Toni Whistler Breakdown of academic impact, for papers by Keith Redhead Breakdown of academic impact, for papers by Ben Z. Katz Breakdown of academic impact, for papers by Shelley Rhodes Breakdown of academic impact, for papers by Jochem M. D. Galama Breakdown of academic impact, for papers by Michael Pietsch
Rankless by CCL
2026